Key result
One-night application of adaptive servo-ventilation eliminated Cheyne-Stokes respiration and significantly improved AHI (p=0.001), pro-BNP (p=0.036), and walking distance (p=0.018).
Why the study?
Sleep-related breathing disorders can influence the prognosis of chronic heart failure, but the effects of adaptive servo-ventilation as a therapeutic modality needed evaluation.
Does adaptive servo-ventilation improve sleep-related breathing disorders, pro-BNP, and functional capacity in patients with heart failure?
Observational (n=32)
Does adaptive servo-ventilation improve sleep-related breathing disorders, pro-BNP, and functional capacity in patients with heart failure?
p-value: p=0.001
In patients with heart failure and sleep-related breathing disorders, a one-night application of adaptive servo-ventilation effectively eliminated Cheyne-Stokes respiration and central apneas while improving pro-BNP and functional capacity.
ASV may aid acute HF-CSR management; hypothesis-generating and leaves open need for randomized confirmation.
Objective: Sleep-related breathing disorders (SRBD) as obstructive apnea, central apnea, and Cheyne-Stokes respiration (CSR), can be seen in patients with chronic heart failure. SRBD can influence the prognosis of heart failure. We aim to reveal sleep-related breathing disorders in heart failure patients and display the effects of adaptive servo-ventilation (ASV) as a new therapeutic modality. Materials and Methods: In this prospective study, 32 patients with heart failure were included. One night polysomnography (PSG) was done. Results: According to the results of PSG, the SRBD ratio was 96.7%. Continuous positive airway pressure (CPAP) and ASV titrations were offered to all patients with an apnea-hypopnea index (AHI) > 5. Demographics, clinical properties, symptoms, PSG findings, Cheyne-Stokes respiration (CSR), and echocardiography results were recorded. Before and after ASV titration, pulmonary function tests and walking tests were performed, and concentrations of transferrin and pro-BNP were recorded. In the groups according to the AHI, severe obstructive sleep apnea syndrome (OSAS) in 18 of 30 patients, four moderate OSAS, five mild OSAS, and two central sleep apnea (CSA). PSG and, CPAP, ASV titrations were done in 7 male and one female patient that obstructive apnea, central apnea, AHI, arousal, and SpO2 min values had significant improvements (p=0,001, p=0,016, p=0,001, p=0,015 and p=0,008 respectively). We determined all CSRs were eliminated with ASV. After ASV titration pro-BNP, walking distance, and FVC values changed significantly (p=0,036, p=0,018, and p=0,018 respectively). Conclusion: As a result, we determined CSR and central apneas persisted with CPAP but were eliminated with a one-night ASV application. ASV also decreased pro-BNP and increased FVC and walking distance values significantly.
No takes yet. Share an insight, caveat, or question.
Yarar et al. (2023) conducted an observational in Heart failure (n=32). Adaptive servo-ventilation (ASV) vs. Continuous positive airway pressure (CPAP) and baseline was evaluated on Improvements in obstructive apnea, central apnea, AHI, arousal, and SpO2 min values (p=0.001). One-night application of adaptive servo-ventilation eliminated Cheyne-Stokes respiration and significantly improved AHI (p=0.001), pro-BNP (p=0.036), and walking distance (p=0.018).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: